Diabetes News and Research

Latest Diabetes News and Research

COVID-19 patients in high-altitude ICUs had improved survival in case study

A team of researchers in Ecuador and the U.K. found that high altitudes may be linked to improved COVID-19 survival – particularly among patients with no comorbidities.

28 Jan 2021

Study: Diabetics worry about disruption to insulin supplies owing to Brexit outcome

Diabetics living in the UK worry about disruption to insulin supplies as a result of Brexit, new research shows.

27 Jan 2021

Study examines the causes behind antibiotic overuse

The overuse of antibiotics occurs due to the mistaken widespread belief that they are beneficial for a broad array of conditions and because many physicians are willing to prescribe antibiotics if patients ask for the medication, according to a Rutgers study.

27 Jan 2021

Temperature, latitude correlate with COVID-19 cases and mortality rates

With cities around the globe locking down yet again amid soaring COVID-19 numbers, could seasonality be partially to blame? New research from the University of Illinois says yes.

27 Jan 2021

Salk scientists receive $1.2 million from Larry L. Hillblom Foundation to study aging mechanisms

A collaborative team of Salk scientists led by Professor John Reynolds will receive $1.2 million over four years as part of a Network Grant from the Larry L. Hillblom Foundation to examine aging across the life span, including age-related neurodegenerative diseases such as Alzheimer's disease.

27 Jan 2021

Study uncovers a novel promising target for diabetes treatment

Researchers have discovered a novel and druggable insulin inhibitory receptor, named inceptor. The latest study from Helmholtz Zentrum Muenchen, the Technical University of Munich and the German Center for Diabetes Research is a significant milestone for diabetes research as the scientific community celebrates 100 years of insulin and 50 years of insulin receptor discovery.

27 Jan 2021

UVA receives $4.4 million federal grant to expand Interactive Home Monitoring program

A three-year, $4.4 million Federal Communications Commission grant will enable UVA Health to expand its Interactive Home Monitoring care for patients with serious and chronic conditions, including COVID-19 and diabetes.

27 Jan 2021

COVID-19 will impact cardiovascular disease deaths for years to come, warn experts

Heart disease remains the leading cause of death worldwide, according to the American Heart Association's Heart Disease and Stroke Statistics -- 2021 Update, published today in the Association's flagship journal Circulation, and experts warn that the broad influence of the COVID-19 pandemic will likely continue to extend that ranking for years to come.

27 Jan 2021

If I have cancer, dementia or MS, should i get the covid vaccine?

As public demand grows for limited supplies of covid-19 vaccines, questions remain about the vaccines' appropriateness for older adults with various illnesses.

27 Jan 2021

New study provides both good and bad news about transient ischemic attacks

Study findings released Tuesday in the Journal of the American Medical Association (JAMA) hold both good news and bad news about transient ischemic attacks (TIAs), which are harbingers of subsequent strokes.

27 Jan 2021

Hybrid closed-loop insulin therapy improves glycemic control in adolescents, young adults

Hybrid closed-loop insulin therapy improved glycemic control in adolescents and young adults with type 1 diabetes. These outcomes, derived from the International Diabetes Closed-Loop (iDCL) Trial, are reported in the peer-reviewed journal Diabetes Technology & Therapeutics (DTT).

27 Jan 2021

New data shows that mINDY gene is involved in blood pressure regulation

Authors from the German Center for Diabetes Research (DZD) presented data showing that the longevity gene mammalian Indy (mINDY) is involved in blood pressure regulation in the Journal of Clinical Investigation (JCI) insight.

27 Jan 2021

New compound could lead to a new class of diabetes drugs

Research led by The Ohio State University Wexner Medical Center and College of Medicine identified a new compound that might serve as a basis for developing a new class of drugs for diabetes.

27 Jan 2021

New compound may slow aging and age-related diseases

A compound that extends lifespan in a tiny nematode worm slows bone loss in aging mice. That surprising result comes from a longitudinal and functional study of 700 aging mice at the Buck Institute, a project that provides a treasure trove of data for researchers aiming to develop therapeutics to slow aging and age-related diseases.

27 Jan 2021

Researchers develop new computational method for studying genetic and environmental interactions

Researchers at Weill Cornell Medicine and Cornell University's Ithaca campus have developed a new computational method for studying genetic and environmental interactions and how they influence disease risk.

27 Jan 2021

Two-drug combination approach could be effective against bone cancer

An innovative approach to treating bone tumors - starving cancer cells of the energy they need to grow - could one day provide an alternative to a commonly used chemotherapy drug without the risk of severe side effects, suggests a new study from Washington University School of Medicine in St. Louis.

27 Jan 2021

Initial stages of breast cancer could be detected more accurately with new proteomics-based technology

Breast cancer, even at its initial stages, could be detected earlier and more accurately than current techniques using blood samples and a unique proteomics-based technology, according to findings of a study led by the Translational Genomics Research Institute (TGen), an affiliate of City of Hope.

26 Jan 2021

Study shows why children of obese mothers have propensity to develop metabolic diseases

A Brazilian study published in the journal Molecular Human Reproduction helps understand why obese mothers tend to have children with a propensity to develop metabolic disease during their lifetime, as suggested by previous research.

26 Jan 2021

'Post-acute COVID-19 syndrome' likely to substantially impact NHS in England

Researchers in the UK have warned that cardiometabolic and pulmonary events among coronavirus disease 2019 (COVID-19) survivors following their discharge from hospital is likely to have an ongoing and substantial impact on the National Health Service (NHS) in England.

26 Jan 2021

New discovery could lead to faster and more effective treatments for chronic health complications

A world-first discovery by researchers at Monash University and The University of Queensland could lead to faster and more effective treatments for chronic health complications, such as cardiovascular disease and cancer, with 'fluorescent' in vivo biosensors.

26 Jan 2021

Diabetes News and Research

Latest Diabetes News and Research

COVID-19 patients in high-altitude ICUs had improved survival in case study

Study: Diabetics worry about disruption to insulin supplies owing to Brexit outcome

Study examines the causes behind antibiotic overuse

Temperature, latitude correlate with COVID-19 cases and mortality rates

Salk scientists receive $1.2 million from Larry L. Hillblom Foundation to study aging mechanisms

Study uncovers a novel promising target for diabetes treatment

UVA receives $4.4 million federal grant to expand Interactive Home Monitoring program

COVID-19 will impact cardiovascular disease deaths for years to come, warn experts

If I have cancer, dementia or MS, should i get the covid vaccine?

New study provides both good and bad news about transient ischemic attacks

Hybrid closed-loop insulin therapy improves glycemic control in adolescents, young adults

New data shows that mINDY gene is involved in blood pressure regulation

New compound could lead to a new class of diabetes drugs

New compound may slow aging and age-related diseases

Researchers develop new computational method for studying genetic and environmental interactions

Two-drug combination approach could be effective against bone cancer

Initial stages of breast cancer could be detected more accurately with new proteomics-based technology

Study shows why children of obese mothers have propensity to develop metabolic diseases

'Post-acute COVID-19 syndrome' likely to substantially impact NHS in England

New discovery could lead to faster and more effective treatments for chronic health complications

Industry Focus eBook - Medical device (1st edition) eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Diabetes News and Research

Latest Diabetes News and Research

Industry Focus eBook - Medical device (1st edition) eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in